Phenprocoumon and Amitriptyline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Amitriptyline
Phenprocoumon
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You're taking amitriptyline (an antidepressant) along with phenprocoumon, a blood thinner. When these two are used together, the amitriptyline can make your body hold onto the blood thinner longer and absorb more of it. That means the blood thinner may build up and work more strongly than expected, which raises your risk of bleeding.
This change tends to happen gradually, not right away, and it can vary a lot from person to person. The good news is this is very manageable. Your care team can check your INR (a simple blood test that measures how thin your blood is) and adjust your dose to keep you in a safe range. Keep taking both as prescribed, and let your team know if you notice unusual bruising or bleeding.
Effect: Increased risk of bleeding from enhanced anticoagulant effect.
Mechanism: Amitriptyline (TCA) is thought to decrease phenprocoumon metabolism and increase its bioavailability, raising phenprocoumon exposure (increased half-life and AUC). Neither agent is a prodrug requiring activation, so the direction is a straightforward potentiation of anticoagulation.
- Direction: Increased phenprocoumon effect (bleeding risk)
- Onset: Delayed
- Evidence: Probable; considerable interindividual variability
- NTI drug: Yes (oral anticoagulant)
Management: Monitor PT/INR closely when starting or stopping amitriptyline and reassess periodically during concurrent use. Anticoagulant dose may need individualized adjustment; a stable regimen can be difficult to achieve.
What happens
An increased risk of bleeding
Interaction Deep Dive
Oral anticoagulants may exhibit a prolonged half-life and enhanced bioavailability when combined with tricyclic antidepressants (TCAs)23. Substantial variation between individuals can occur1.
Why it happens (mechanism)
Decreased phenprocoumon metabolism; increased phenprocoumon absorption
How to manage this interaction
This combination is manageable with monitoring and dose tailoring by your care team.
- Keep taking both exactly as prescribed unless your prescriber tells you otherwise.
- Your team will likely check your INR more often, especially when amitriptyline is started or stopped, and periodically while you take both.
- Your blood thinner dose may need to be adjusted and individualized to keep your anticoagulation in the target range.
- Tell your pharmacist or doctor about any unusual bruising, nosebleeds, blood in urine or stool, or bleeding that won't stop.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
3 reports — tap to read
a) In an investigation involving healthy volunteers, the simultaneous administration of nortriptyline or amitriptyline led to elevated dicumarol concentrations and a longer plasma half-life of dicumarol, though this effect was not seen uniformly across all participants 1. Such an effect did not occur with warfarin.
b) Administration of a single oral dose of bishydroxycoumarin following 8 days of nortriptyline produced a markedly prolonged half-life and a reduced volume of distribution of the coumarin anticoagulant in 6 healthy volunteers 2. The proposed mechanism was decreased bishydroxycoumarin metabolism and/or changes in coumarin absorption.
c) Drug dosing was examined in 16 patients receiving long-term anticoagulant therapy who were concurrently taking TCAs 3. The TCAs influenced the stability of anticoagulant control, resulting in frequent adjustments to the anticoagulant doses. The suggested mechanism was inhibition of coumarin metabolism.
Common questions
Can I take Phenprocoumon and Amitriptyline together?
Amitriptyline can boost phenprocoumon's blood-thinning effect and raise bleeding risk, so your care team should monitor your INR closely and adjust the blood thinner dose as needed. Keep taking both as prescribed and report any unusual bleeding or bruising. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Phenprocoumon and Amitriptyline interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How is the Phenprocoumon and Amitriptyline interaction managed?
This combination is manageable with monitoring and dose tailoring by your care team. Keep taking both exactly as prescribed unless your prescriber tells you otherwise. Your team will likely check your INR more often, especially when amitriptyline is started or stopped, and periodically while you take both. Your blood thinner dose may need to be adjusted and individualized to keep your anticoagulat… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Phenprocoumon or Amitriptyline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
References (3)
- Pond SM, Graham GG, Birkett DJ, et al: Effects of tricyclic antidepressants on drug metabolism. Clin Pharmacol Ther 1975; 18:191-199. PubMed
- Vesell ES, Passananti GT, & Greene FE: Impairment of drug metabolism in man by allopurinol and nortriptyline. N Engl J Med 1970; 283:1484-1488. PubMed
- Williams JR, Griffin JP, & Parkins A: Effect of concomitantly administered drugs on the control of long term anticoagulant therapy. Q J Med 1976; 45:63-73. DOI
Keep reading about Amitriptyline
Keep reading about Phenprocoumon
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist